Manas AI is reimagining drug discovery by bringing together world-class biomedical expertise and next-gen AI to pioneer faster, cheaper, more precise medicines. Honored to back Reid Hoffman, Dr. Siddhartha Mukherjee, and the team as they take on this urgent work.
Proud to back Manas AI – co-founded by Reid Hoffman and Dr. Siddhartha Mukherjee – on its mission to accelerate cures for diseases like cancer. Reid has been a champion of Westbound Equity Partners from the beginning, investing in our funds and pushing us to back bold founders whose work expands opportunity. When we learned what he and Siddhartha were building at Manas – an AI-native, full-stack drug discovery company working with partners like Microsoft – we jumped at the opportunity to join the team on this important mission. Why Manas matters: - Science-grounded AI: neuro-symbolic, foundation models designed for faster, more precise discovery. - World-class leadership: Dr. Mukherjee’s biomedical excellence paired with Reid’s company-building DNA. Now Ujjwal Singh joining as Co-Founder & CTO brings serious scale experience. - Real urgency: a path to therapies that reach patients sooner and at lower cost. Investing in Manas is about speed to breakthrough and broad access to the benefits of those breakthroughs. Congratulations to the Manas team! More on the latest with Manas AI Linked in comments.